These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 19387532)

  • 1. Usefulness of Sonazoid contrast-enhanced ultrasonography for hepatocellular carcinoma: comparison with pathological diagnosis and superparamagnetic iron oxide magnetic resonance images.
    Korenaga K; Korenaga M; Furukawa M; Yamasaki T; Sakaida I
    J Gastroenterol; 2009; 44(7):733-41. PubMed ID: 19387532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Kupffer-phase Sonazoid-enhanced sonography and hepatobiliary-phase gadoxetic acid-enhanced magnetic resonance imaging of hepatocellular carcinoma and correlation with histologic grading.
    Sugimoto K; Moriyasu F; Saito K; Taira J; Saguchi T; Yoshimura N; Oshiro H; Imai Y; Shiraishi J
    J Ultrasound Med; 2012 Apr; 31(4):529-38. PubMed ID: 22441909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging of hepatocellular carcinoma: qualitative and quantitative analysis of postvascular phase contrast-enhanced ultrasonography with sonazoid. Comparison with superparamagnetic iron oxide magnetic resonance images.
    Inoue T; Kudo M; Hatanaka K; Takahashi S; Kitai S; Ueda T; Ishikawa E; Hagiwara S; Minami Y; Chung H; Ueshima K; Maekawa K
    Oncology; 2008; 75 Suppl 1():48-54. PubMed ID: 19092272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential diagnosis of nodular lesions in cirrhotic liver by post-vascular phase contrast-enhanced US with Levovist: comparison with superparamagnetic iron oxide magnetic resonance images.
    Inoue T; Kudo M; Watai R; Pei Z; Kawasaki T; Minami Y; Chung H; Fukunaga T; Awai K; Maenishi O
    J Gastroenterol; 2005 Dec; 40(12):1139-47. PubMed ID: 16378178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superparamagnetic iron oxide-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading.
    Imai Y; Murakami T; Yoshida S; Nishikawa M; Ohsawa M; Tokunaga K; Murata M; Shibata K; Zushi S; Kurokawa M; Yonezawa T; Kawata S; Takamura M; Nagano H; Sakon M; Monden M; Wakasa K; Nakamura H
    Hepatology; 2000 Aug; 32(2):205-12. PubMed ID: 10915725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Images of Sonazoid-enhanced ultrasonography in multistep hepatocarcinogenesis: comparison with Gd-EOB-DTPA-enhanced MRI.
    Ohama H; Imai Y; Nakashima O; Kogita S; Takamura M; Hori M; Seki Y; Sawai Y; Igura T; Fukuda K; Makino Y; Morimoto O; Ohsawa M; Sakamoto M; Murakami T
    J Gastroenterol; 2014 Jun; 49(6):1081-93. PubMed ID: 23903870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between contrast-enhanced intraoperative ultrasound using Sonazoid and histologic grade of resected hepatocellular carcinoma.
    Arita J; Hasegawa K; Takahashi M; Hata S; Shindoh J; Sugawara Y; Kokudo N
    AJR Am J Roentgenol; 2011 Jun; 196(6):1314-21. PubMed ID: 21606294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of well-differentiated hepatocellular carcinomas from other hepatocellular nodules in cirrhotic liver: value of SPIO-enhanced MR imaging at 3.0 Tesla.
    Park HS; Lee JM; Kim SH; Chang S; Kim SJ; Han JK; Choi BI
    J Magn Reson Imaging; 2009 Feb; 29(2):328-35. PubMed ID: 19161184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Correlation between SPIO-enhanced magnetic resonance imaging (MRI) and histological grading in hepatocellular carcinoma].
    Zhang XH; Liang BL; Huang SQ
    Ai Zheng; 2003 Jul; 22(7):734-8. PubMed ID: 12866966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kupffer phase image of Sonazoid-enhanced US is useful in predicting a hypervascularization of non-hypervascular hypointense hepatic lesions detected on Gd-EOB-DTPA-enhanced MRI: a multicenter retrospective study.
    Inoue T; Hyodo T; Korenaga K; Murakami T; Imai Y; Higaki A; Suda T; Takano T; Miyoshi K; Koda M; Tanaka H; Iijima H; Ochi H; Hirooka M; Numata K; Kudo M
    J Gastroenterol; 2016 Feb; 51(2):144-52. PubMed ID: 26373860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of arterial-phase hyperenhancement and late-phase washout of hepatocellular carcinoma-a meta-analysis of contrast-enhanced ultrasound (CEUS) with SonoVue® and Sonazoid®.
    Ren J; Lu Q; Fei X; Dong Y; D Onofrio M; Sidhu PS; Dietrich CF
    Eur Radiol; 2024 Jun; 34(6):3795-3812. PubMed ID: 37989916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visibility of focal liver lesions: Comparison between kupffer phase of CEUS with sonazoid and hepatobiliary phase of gadoxetic acid-enhanced MRI.
    Yang WY; Park HS; Kim YJ; Yu MH; Jung SI; Jeon HJ
    J Clin Ultrasound; 2017 Nov; 45(9):542-550. PubMed ID: 28547764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of combination of imaging modalities in the diagnosis of hepatocellular carcinoma using Sonazoid®-enhanced ultrasound, gadolinium diethylene-triamine-pentaacetic acid-enhanced magnetic resonance imaging, and contrast-enhanced computed tomography.
    Alaboudy A; Inoue T; Hatanaka K; Chung H; Hyodo T; Kumano S; Murakami T; Moustafa EF; Kudo M
    Oncology; 2011; 81 Suppl 1():66-72. PubMed ID: 22212939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intra-individual comparison of Sonazoid contrast-enhanced ultrasound and SonoVue contrast-enhanced ultrasound in diagnosing hepatocellular carcinoma.
    Guo D; Wan W; Bai X; Wen R; Peng J; Lin P; Liao W; Huang W; Liu D; Peng Y; Kang T; Yang H; He Y
    Abdom Radiol (NY); 2024 May; 49(5):1432-1443. PubMed ID: 38584190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and Comparison of Prediction Models Based on Sonovue- and Sonazoid-Enhanced Ultrasound for Pathologic Grade and Microvascular Invasion in Hepatocellular Carcinoma.
    Zhang R; Li D; Chen Y; Xu W; Zhou W; Lin M; Xie X; Xu M
    Ultrasound Med Biol; 2024 Mar; 50(3):414-424. PubMed ID: 38155069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SPIO-enhanced MRI findings of well-differentiated hepatocellular carcinomas: correlation with MDCT findings.
    Kim SH; Lee WJ; Lim HK; Park CK
    Korean J Radiol; 2009; 10(2):112-20. PubMed ID: 19270856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of contrast-enhanced sonography of small hepatocellular carcinoma with sonazoid prior to radiofrequency ablation.
    Lee SJ; Won HJ; Kim KW; Shin YM; Kim PN
    J Clin Ultrasound; 2017 Sep; 45(7):383-390. PubMed ID: 28271531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of post-vascular phase (Kupffer imaging) by contrast-enhanced ultrasonography using Sonazoid in the detection of hepatocellular carcinoma.
    Goto E; Masuzaki R; Tateishi R; Kondo Y; Imamura J; Goto T; Ikeda H; Akahane M; Shiina S; Omata M; Yoshida H; Koike K
    J Gastroenterol; 2012 Apr; 47(4):477-85. PubMed ID: 22200940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New malignant grading system for hepatocellular carcinoma using the Sonazoid contrast agent for ultrasonography.
    Tanaka H; Iijima H; Higashiura A; Yoh K; Ishii A; Takashima T; Sakai Y; Aizawa N; Iwata K; Ikeda N; Iwata Y; Enomoto H; Saito M; Imanishi H; Hirota S; Fujimoto J; Nishiguchi S
    J Gastroenterol; 2014 Apr; 49(4):755-63. PubMed ID: 23720089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Additional value of SPIO-enhanced MR imaging for the noninvasive imaging diagnosis of hepatocellular carcinoma in cirrhotic liver.
    Yoo HJ; Lee JM; Lee JY; Kim SH; Kim SJ; Han JK; Choi BI
    Invest Radiol; 2009 Dec; 44(12):800-7. PubMed ID: 19838119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.